Highest-materiality recent filing
RYAM Q1 net loss $81M ($1.22/sh), adjusted EBITDA $8M; strategic review underway
Net sales $319M, down 10% YoY from $353M; net loss $81M vs loss $32M prior year, including $41M non-cash idling charge.
RYAM CEO resigns; board launches strategic alternatives review with Morgan Stanley
CEO Scott M. Sutton resigned effective April 16, 2026.
RYAM Q4 2025 loss $21M, sales $417M; full-year Adj EBITDA $133M, negative FCF $88M
Q4 loss from continuing ops $21M ($0.32 diluted EPS) vs loss $16M in prior year; net sales $417M, down $5M.
Rayonier Advanced Materials abandons Altamaha Green Energy project
Company will not advance participation in the Altamaha Green Energy project after comprehensive review.
Rayonier Advanced Materials appoints Scott Sutton as CEO, effective Jan 5, 2026
Scott Sutton, former Olin CEO, succeeds DeLyle Bloomquist who steps down as CEO and board member.
RYAM CEO De Lyle W. Bloomquist to retire by May 2026; board launches search
President and CEO De Lyle W. Bloomquist to retire by May 2026 annual meeting; will remain until successor named.
RYAM Q3 net loss narrows to $4M; FY2025 Adjusted EBITDA guided $135-140M
Q3 net sales $353M (-$48M YoY); loss from cont ops $4M vs $33M loss YoY.
RYAM and USW file antidumping petitions on Brazil and Norway HPDP imports
Petitions allege HPDP dumping margins up to 168% (Brazil) and 226% (Norway); 30 Brazilian subsidy programs cited.
RYAM Q2 net loss $363M on $337M DTA write-off; cuts 2025 EBITDA guidance to $150-160M
Net loss of $363M ($5.44/diluted share) vs. prior-year income of $11M; includes $337M non-cash Canadian deferred tax asset write-off.
RYAM reports Q1 net loss $32M; lowers FY 2025 Adj. EBITDA guidance to $175-185M
Net loss $32M ($0.49/diluted share) vs net loss $2M prior year; revenue $356M down 8% YoY.
RYAM 2024 adj. EBITDA $222M (+60% YoY); guides 2025 $215-235M
Net sales $1,630M (-$13M YoY); loss from cont. ops $42M vs $102M loss prior year.
RYAM reports preliminary FY2024: Adj. EBITDA $222M (+60%); tariff impact up to $3.5M/month
Net sales $1,639M (flat YoY); loss from cont. ops $43M, improved $59M.
RYAM raises €67M green capital for BioNova subsidiary; targets $40M+ EBITDA by 2027
€37M secured term loans from Crédit Lyonnais, Arkéa Banque, BNP Paribas at ~5% floating rate, ~7-year maturity.
RYAM closes $700M term loan, repays existing debt, extends ABL to 2029
Borrowed $700M under new senior secured term loan facility to refinance existing debt and redeem 7.625% 2026 Notes.
RYAM Q3 net loss $33M on impairment; reiterates EBITDA, ups FCF guidance; $700M refinancing
Q3 net loss $33M ($0.49/diluted) vs $25M loss last year; includes $25M asset impairment and $7M suspension charges.
RYAM closes $700M secured term loan to refinance 2026 notes and existing debt
$700M senior secured term loan from Oaktree, Silver Point, Blue Torch; interest = 3M Term SOFR + 7.00%.
RYAM Q2 net income $11M vs loss; raises 2024 EBITDA outlook to $205-215M
Net income $11M ($0.17/diluted) vs net loss of $17M (-$0.26) in Q2 2023; revenue $419M, up $34M.
RYAM Reports Q1 Net Loss $2M, Adj EBITDA $52M; Raises 2024 FCF Guidance
Net loss $2M ($0.02/diluted share) vs net income $2M in prior year; revenue $388M, down $79M YoY.
Indefinite suspension of Temiscaming HPC plant due to market weakness and high costs.
RYAM reports 2023 loss of $102M; guides 2024 Adjusted EBITDA $180-200M
Net sales $1,643M (-$74M YoY); loss from continuing ops $102M (incl. $62M non-cash impairment) vs. loss $27M prior year.
Effective September 9, 2024, the Company’s Board elected Eric M. Bowen as a Class I independent director of the Company to serve until the 2027 annual meeting of the stockholders of the Company and thereafter until his successor has been duly elected and qualified, or until his earlier death, resignation or removal.
Charles E. Adair tendered his resignation from the Board of Directors (the “Board”) of Rayonier Advanced Materials Inc. (the “Company”) effective 11:59 p.m. (EDT) on September 8, 2024.
Max materiality 0.85 · Median 0.70 · Most common event earnings